semaglutide and liver enzymes The weight-loss-independent hepatoprotective benefits of are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors Could semaglutide one day help

A randomized trial of mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome from COVID-19

For best results, follow with a soothing mask or hydrating serum

In many cases, these people have what is known as subclinical hypothyroidism

Only case reports, case series, retrospective chart reviews, open-label trials, and randomized controlled trials (RCTs) were considered

February 2026 marked a meaningful expansion in the oral GLP-1 landscape, with new data adding to the momentum that began with the FDA approval of oral Wegovy (semaglutide 25 mg tablets) in late 2025

While the largest potential absolute benefit by race/ethnicity was observed in non-Hispanic White individuals, with 86,010 MACE (~ 14%), 21,123 cardiovascular deaths (~ 6%), 64,602 nonfatal myocardial infarctions (~ 25%), and 18,864 nonfatal strokes (~ 11%) prevented